moxisylyte has been researched along with Mydriasis in 2 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Mydriasis: Dilation of pupils to greater than 6 mm combined with failure of the pupils to constrict when stimulated with light. This condition may occur due to injury of the pupillary fibers in the oculomotor nerve, in acute angle-closure glaucoma, and in ADIE SYNDROME.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pfeiffer, N | 1 |
| Grehn, F | 1 |
| Wellek, S | 1 |
| Schwenn, O | 1 |
| Sharma, A | 1 |
| Votruba, M | 1 |
1 trial available for moxisylyte and Mydriasis
| Article | Year |
|---|---|
Intraocular thymoxamine or acetylcholine for the reversal of mydriasis.
Topics: Acetylcholine; Adolescent; Adult; Aged; Aged, 80 and over; Cataract Extraction; Child; Drug Therapy, | 1994 |
1 other study available for moxisylyte and Mydriasis
| Article | Year |
|---|---|
Thymoxamine in the treatment of traumatic mydriasis.
Topics: Adult; Eye Injuries; Humans; Middle Aged; Moxisylyte; Mydriasis | 1993 |